Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Ticker Scorecard - RNAZ

Basics
Company: TransCode Therapeutics, Inc.
IPO Date: July 9, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $5.62M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.11 | 6.03%
Avg Daily Range (30 D): $0.65 | 9.67%
Avg Daily Range (90 D): $0.33 | 7.64%
Institutional Daily Volume
Avg Daily Volume: .1M
Avg Daily Volume (30 D): 2.5M
Avg Daily Volume (90 D): .88M
Trade Size
Avg Trade Size (Sh.): 21
Avg Trade Size (Sh.) (30 D): 101
Avg Trade Size (Sh.) (90 D): 85
Institutional Trades
Total Inst.Trades: 16
Avg Inst. Trade: $.76M
Avg Inst. Trade (30 D): $.58M
Avg Inst. Trade (90 D): $.58M
Avg Inst. Trade Volume: .02M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $.65M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: .01K
   
News
Jul 23, 2024 @ 5:26 PM
Why Transcode Therapeutics (RNAZ) Stock Is Down 60...
Source: Henry Khederian
Jun 10, 2024 @ 12:07 PM
Beat the Market Like Zacks: Goldman Sachs, Micron,...
Source: Abhinab Dasgupta
Jun 10, 2024 @ 11:00 AM
Nasdaq Determines That TransCode Therapeutics Has ...
Source: TransCode Therapeutics, Inc.
May 29, 2024 @ 1:15 PM
TransCode Therapeutics Reports Positive Data from ...
Source: TransCode Therapeutics, Inc.
May 12, 2024 @ 10:18 AM
Successful Penny Stocks Trader Tips, 3 To Use
Source: D. Marie
Financials
  TTM Q2 2024 Q1 2024
Basic EPS $-98.23 $-.74 $-.65
Diluted EPS $-98.23 $-.74 $-.65
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -17.91M $ -5.19M $ -3.33M
Operating Income / Loss $ -17.79M $ -5.11M $ -3.29M
Cost of Revenue $ $ $
Net Cash Flow $ -.22M $ -1.56M $ 2.15M
PE Ratio    
Splits
Dec 04, 2024:   33:1
Jan 16, 2024:   40:1
May 23, 2023:   20:1